Dry eye is one of the most common diseases in ophthalmology. In almost 60% of those affected, the cause is a so-called lipid phase disorder(1), which is manifested by complaints such as watery and burning eyes. Often the complaints are more pronounced in the morning. Causes of these complaints can be the intensive use of PC, smartphone and laptop. But also drafts, air conditioning or unfavorable climatic influences such as cold wind can promote these complaints. With EvoTears®, an unprecedented therapy class for the treatment of dry eyes due to a lipid phase disorder has been available since 2015. EvoTears®, the unique(2) lipid replacement, convinces with its efficacy and tolerability and is suitable for the majority of dry eye sufferers.
(1) Tong L. et al. Invest Ophthalmol Vis Sci 2010, 51: 3449-3454.
(2) Due to perfluorohexyloctane and anhydrous.